The first shipment of essential medications for cancer, blood diseases, and immune disorders has arrived in Benghazi, marking a major step in the Parliament-backed government’s plan to improve healthcare access across Libya.
Libya’s Prime Minister, Dr Osama Hammad, conducted a field inspection in Benghazi to oversee the arrival and storage of the new medications. He was accompanied by the Head of the Administrative Control Authority, Khaled Najm, and the Director-General of the Medical Supply and Therapeutic Services Authority, Hatem Al-Oraibi.
The shipment includes more than 80 pharmaceutical types, sourced directly from certified American and European manufacturers. According to officials, the medications meet Libya’s approved standards and specifications. This move falls within the broader government effort to provide critical treatments for citizens, following the directives of Field Marshal Khalifa Haftar, Commander-in-Chief of the Libyan National Army (LNA).
Authorities confirmed that the medications will be distributed through a dedicated electronic system to ensure they reach registered patients on time and without interruption. The digital monitoring mechanism is designed to prevent misuse and guarantee fair and organised delivery across all Libyan cities.
The government also stated that the current supplies will cover the full course of treatment for all patients registered in hospitals and specialist medical centres nationwide. Further shipments are expected in the coming weeks to maintain availability and continuity of care.
This development is part of a national strategy to reinforce the health sector and meet urgent needs, especially for those suffering from chronic and life-threatening conditions. The government has pledged to continue importing necessary medications and to expand healthcare services to reduce the burden on patients and families.
The Benghazi-based government sees this initiative as a model for improving healthcare provision throughout Libya.
